NCT05135923View on ClinicalTrials.gov

Glutenfree, Gut Microbiota and Metabolic Regulation

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions

Celiac Disease

Interventions

DIETARY_SUPPLEMENT

Randomized, controlled trial (RCT) with parallel arms and double blinded

Experiment group receive optimized gluten free products (high in fiber and whole grain) compared to comparable benchmark gluten free products (control group).

Trial Locations (1)

0130

Oslo Metropolitan University, Oslo

All Listed Sponsors

collaborator

University of Oslo

OTHER

collaborator

Det Glutenfrie Verksted

UNKNOWN

lead

Oslo Metropolitan University

OTHER

NCT05135923 - Glutenfree, Gut Microbiota and Metabolic Regulation | Biotech Hunter | Biotech Hunter